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Acute coagulopathy is prevalent in adult and pediatric trauma patients and is associated
with increased morbidity and mortality. While reasonable hypotheses have been created
to explain the underlying perturbations of adult trauma coagulopathy (i.e., tissue
factor-related increase in thrombin generation, protein C activation, hypoperfusion, and
hyperfibrinolysis), only a small number of studies have been performed to prove whether
these mechanisms can likewise be detected in pediatric trauma patients. In addition,
severe hypofibrinogenemia (<100mg/dL) is a frequent finding in pediatric trauma patients
(>20%). Although the probability of life-threatening coagulopathy is low with minor to
moderate injury, it is present in almost all patients with an injury severity score >25,
hypotension, hypothermia, and acidosis. As these multifactorial changes in hemostasis
cannot be adequately and rapidly measured using standard laboratory testing, the use
of viscoelastic measurements has been established in adult trauma management, but
prospective studies in children are urgently needed. Apart from diagnostic challenges,
several studies have focused on the impact of blood product ratios on the treatment of
massively bleeding pediatric trauma patients. The majority of these studies were unable
to show improved survival by using higher plasma to red blood cell ratios or higher platelet
to red blood cells ratios, but there are no published randomized trials to definitively answer
this question. A goal-directed transfusion protocol using viscoelastic tests together
with early substitution with an antifibrinolytic and fibrinogen replacement is a promising
alternative to traditional ratio-based interventions. Another crucial factor in treating
trauma-induced coagulopathy is the early detection of hypofibrinogenemia, a common
condition in massively transfused patients. Early treatment of hypofibrinogenemia is
associated with improved morbidity and mortality in adults, but needs to be further
studied in future pediatric trials. Pediatric trauma patients are not only threatened by
coagulopathy-related bleeding but are also at higher risk for venous thromboembolism.
Pediatric trauma patients with brain injury, central venous catheters, immobilization, or
surgical procedures are at highest risk for developing a deep venous thrombosis. There
are no specific pediatric guidelines established to prevent venous thromboembolism in
children suffering from traumatic injury.
Keywords: trauma, massive bleeding, thrombosis, viscoelastic testing, transfusion, pediatrics, coagulation factor
concentrates
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INTRODUCTION
Adult traumatic coagulopathy is a commonly studied, but not
fully understood, condition that occurs early and is a major
contributor to injury-related mortality (1, 2). Its presence is
usually defined by detection of impaired plasmatic coagulation
parameters, such as a prolonged prothrombin time (PT) or
activated partial thromboplastin time (aPTT) or increased
International Normalized Ratio (INR). The occurrence of a
prolonged PT or increased INR (specifically INR of ≥1.3 at
admission) is associated with mortality in trauma patients (3, 4).
Although INR seems to predict mortality, prospective data from
adult surgical and trauma patients have shown that INR is not
a reliable indicator of coagulopathy and should not be used to
guide factor replacement (5).
While initial theories to describe trauma-related coagulopathy
were based on the effects of hemodilution due to the
administration of large amounts of coagulation factor-free
solutions, the knowledge about the pathophysiologic changes
have evolved substantially. The current understanding of
trauma-induced coagulopathy is still evolving, but the main
underlying causes are thought to be hemorrhagic shock-related
hypoxia/hypoperfusion, and tissue injury. Hypoperfusion and
hypoxia promote platelet and endothelial dysfunction that
further trigger activation of protein C and impaired thrombin
generation, as well as major changes in the fibrinolytic pathway
(6). In addition, defects in collagen deposition related to
endothelial dysfunction, downregulated platelet glycoprotein
receptors, and complement activation are all thought to be
contributors to Trauma Induced Coagulopathy (TIC) (7). In
a prospective trial in pediatric trauma patients with an age
of >15 years, the probability of life-threatening coagulopathy
was low with minor to moderate injury, but coagulopathy was
present in almost all patients with an injury severity score
>25, hypotension, hypothermia, and acidosis (8). It is unknown
whether the coagulopathy is similar for children in all age groups
suffering from trauma due to a dearth of prospective studies in
pediatric populations.
In addition to a brief description of TIC in children and
discussion of the major differences between hemostatic changes
in adults and children suffering from trauma, this review will
focus on the management of coagulopathic bleeding in pediatric
trauma patients. Finally, we will review the impact of trauma
on the occurrence of venous thromboembolism, as this is an
important but frequently overlooked counterpart of trauma-
related bleeding complications.
TRAUMA-INDUCED COAGULOPATHY IN
CHILDREN
Overview of TIC in Children
The incidence of TIC in severe pediatric trauma patients in the
emergency room varies tremendously and is reported to be in
the range of 10–77% (9). This remarkable variability may be
explained by the fact that to date no specific pattern of tests
and no specific thresholds are available to define TIC. There is
no universally accepted definition of TIC. In fact, Christiaans et
al. (9) described a huge variety of coagulation parameters and
thresholds from 18 different studies that were used to define TIC
after pediatric trauma (9), thus questioning if the main results of
those studies are comparable. In addition, it is known from the
adult world that changes in hemostasis following trauma do not
uniformly lead to bleeding. There may be transient changes that
lead to hypercoagulability as well.
Although the TIC-related changes in hemostasis and
fibrinolysis of severely injured adult patients can be likewise
observed in children (10), age-dependent differences may occur
due to developmental changes. The overall hemostatic balance
in an infant prevents an increase in bleeding or hypercoagulable
states; however, it is hypothesized that even small changes in this
fragile balance may lead to a coagulopathy in one direction or
the other depending on the type of injury or time period after
injury (10).
The Role of Hypercoagulability and
Fibrinolytic Pathway Abnormalities in
Pediatric Trauma-Induced Coagulopathy
In adult trauma patients, the presence of hyperfibrinolysis is
highly correlated with mortality (11). Fibrinolysis is also a
concern in children. In a cohort of 133 pediatric trauma patients,
19.6% of all children presented with hyperfibrinolysis detected
by rapid thrombelastography. In addition, 38.3% of the children
had fibrinolytic shutdown (12). In that study, hyperfibrinolysis
and fibrinolytic shutdown were both associated with mortality
and the need for blood transfusion, while fibrinolytic shutdown
was additionally associated with disability (e.g., changes in
behavior, intellectual functioning, and locomotion) and deep vein
thrombosis. A prospective follow up study performed by the
same group demonstrated that plasma transfusion and TBI are
both independently associated with fibrinolysis shutdown, and
that the combination of both is associated with a very poor
prognosis, showing a 75% mortality and 100% disability in all
survivors (13). Based on those results, the authors concluded
that TIC is not a single entity, but a broad group of hemostatic
imbalances showing distinct phenotypes.
While the empiric administration of tranexamic acid to
address hyperfibrinolysis has shown to reduce mortality in
adult trauma patients, data in pediatric trauma are scarce (14).
Studies are urgently needed to investigate whether preadmission
administration of tranexamic acid in pediatric civilian trauma
patients has an impact on bleeding and mortality. There are
no studies that address the treatment of fibrinolytic shutdown
in children.
Pathophysiology of the Mechanisms of
Pediatric Trauma (Including Traumatic
Brain Injury)
There is a substantial difference in the underlying mechanisms
of trauma in children as compared to adults: a relatively higher
rate of blunt trauma and non-accidental trauma, including
brain injuries, can be observed in children (15). This is of
particular importance as isolated severe brain injury (TBI) is
a major contributor to the development of trauma-induced
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coagulopathy (TIC), and TIC can be observed in about 42–
44% of all severe TBI cases (16, 17). Indeed, pediatric TBI has
been identified as a common contributor to TIC and mortality
(18). In adult patients suffering from TBI, an early transition
from a hyper- to a hypocoagulable state has been observed
(19, 20). Zhang et al. (21) have demonstrated in a mouse model
that the release of brain-derived cellular microvesicles into the
circulation following brain trauma has served as a causal factor
for induction of a systemic hypercoagulable state, which was
quickly followed by a consumptive coagulopathy. Focusing on
the time course of traumatic brain injury-related coagulopathy,
D-dimers and fibrinogen degradation products can be detected
within minutes of injury, whereas prolonged PT and aPTT are
detected late, reaching their peaks ∼3–6 h post-TBI (19, 20, 22).
The combination of both, a hyper- and hypocoagulable state have
been likewise detected in pediatric TBI (23). Hypercoagulability is
suspected to promote ischemic lesions which can further worsen
the outcome in this setting (9).
Summary
In summary, when TIC is present in pediatric patients the
mortality rate appears to be markedly increased (3, 24).
Unfortunately, the definition of TIC is not yet fully understood,
especially in children, and may encompass several distinct
abnormal hemostatic profiles. Therefore, a timely and reliable
diagnostic workup is a basis for a better understanding of the
hemostatic balance and optimal bleeding management. This will
be discussed in the next section.
DETECTION OF TRAUMA-INDUCED
COAGULOPATHY IN CHILDREN
In addition to reviewing global plasmatic coagulation parameters
(i.e., PT/INR and aPTT) which provide only a simple assessment
of the first phase of clot initiation, it seems worthwhile to
review published evidence of other markers to detect TIC,
such as platelet count, fibrinogen, signs of fibrinolysis and
viscoelastic testing.
Platelet count was significantly associated with mortality in a
cohort of 102 pediatric trauma patients, and an abnormal platelet
count was observed in 23% of all children (15). However, platelet
count does not reflect platelet function, which may also play a
role in TIC (25). In adult patients with TBI, platelet ADP receptor
inhibition was strongly correlated with the severity of brain
injury (6). Unfortunately, sound data in children are lacking to
determine the impact of platelet count and function on TIC, and
clear thresholds are needed to safely guide transfusion therapy.
Severe hypofibrinogenemia (plasma fibrinogen levels below
100 mg/dL) was detected in 20% of the previously mentioned
cohort of pediatric trauma patients (15). It remains unclear if this
was due to hemodilution or consumptive coagulopathy on large
wound surfaces, or because of hyperfibrinolysis.
When viscoelastic testing such as thrombelastography or
thromboelastometry was used to detect TIC in pediatric trauma
patients, signs of hyperfibrinolysis (defined as lysis index of
3.0% or greater or maximum lysis >15%, respectively) (12), a
TABLE 1 | Signs of trauma-induced coagulopathy using standard laboratory
testing (SLT) and viscoelastic testing (VET).
Characteristics Signs in SLT Signs in VET
Impaired initiation of coagulation Prolonged aPTT
Prolonged
PT/elevated INR
Prolonged R-time
(TEG)
Prolonged CT (ROTEM)
Weakening of clot strength Not measurable Reduced MA (TEG)
Reduced
MCF (ROTEM)
Hypofibrinogenemia Reduced value in
Clauss fibrinogen
assay
Reduced MA FF (TEG)
Reduced FIBTEM
MCF (ROTEM)
Hyperfibrinolysis Not measurable LY30 ≥ 3% (TEG)
ML > 15% (ROTEM)
aPTT, activated partial thromboplastin time; PT, prothrombin time; INR, international
normalized ratio; TEG, thrombelastography; ROTEM, thromboelastometry; R-time,
reaction time; CT, clotting time; MA, maximum amplitude; MCF, maximum clot firmness;
FF, functional fibrinogen test; FIBTEM, fibrin polymerization assay; LY30, Clot lysis at
30min after maximum clot strength; ML, maximum lysis at 60min after CT.
prolonged time for initiation of clot building (R-time and k-time,
or clotting time and clot formation time, respectively), as well
as signs of weakening in clot strength (maximum amplitude or
maximum clot firmness, respectively) were observed (26, 27).
Signs of TIC using standard coagulation testing and viscoelastic
testing are shown in Table 1.
PEDIATRIC TRANSFUSION STRATEGIES
There is published evidence that hemorrhagic injuries are less
likely in children, and TBI is the main underlying reason for
mortality. In a cohort of 776 pediatric trauma patients, clinical
bleeding or hemorrhagic injury was only present in 7.0% (n =
54) of all children (4). Although in that study an admission
INR of ≥1.3 was determined to be an independent predictor of
mortality, transfusion of plasma was not effective in changing
INR. The authors have therefore questioned whether an INR
of 1.3 or greater can be used as a precise term to diagnose
coagulopathy in this setting or whether it is just an indicator of
disease severity. It is of great importance to understand and to
distinguish the interpretation of impaired plasmatic coagulation
test results as markers of systemic hemostasis imbalance and
outcome predictors vs. our ongoing efforts to find reliable
laboratory treatment targets for transfusion therapy. Notably,
patients with borderline elevated plasmatic coagulation tests
do not necessarily show signs of disturbed clot initiation in
viscoelastic tests (28, 29). As mentioned before, transfusion of
plasma to treat a moderately elevated INR is not successful
and does not have influence on outcome (4). Therefore, the
transfusion strategy should be adopted primarily based on the
clinical status of a trauma patient, namely by whether clinically
relevant bleeding is present or not. A threshold of 37 ml/kg per
4 h ormore of transfused bloodwas determined to be an indicator
for the need for hemorrhage control procedures and a predictor
of early mortality (30).
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If clinically meaningful hemorrhage is present, immediate
access to blood and blood products is needed. Institutional
protocols should be established. However, there is no evidence
to support transfusion protocols using a 1:1:1 approach of red
blood cells (RBCs), plasma and platelets in pediatrics. Unlike
in the adult setting, several trials have failed to show any
survival benefit by using a transfusion protocol with a predefined
transfusion ratio (31–37). In a retrospective analysis of a cohort
of 364 massively transfused combat-injured children, a high
ratio of plasma to RBC transfusion was associated with a longer
hospital length of stay and was not associated with a mortality
benefit (36). When comparing a cohort of 55 pediatric trauma
patients that were transfused with a protocol using a predefined
massive transfusion ratio, Chidester et al. (31) were not able
to show a significant difference in mortality. There is only one
retrospective data analysis that found a benefit. In this study of
465 pediatric trauma patients that excluded severe isolated head
injury, a survival benefit was detected for children treated with
a high ratio of plasma:RBC, while no differences were observed
among the higher platelet:RBC cohort (38). Given that there
are major differences in terms of definition of coagulopathy and
criteria to activate a massive transfusion protocol in different
published studies, it is hardly surprising that there is no clear
and easy answer as to whether certain transfusion ratios may
have a mortality benefit in civilian pediatric trauma patients.
In addition to study differences, differences in age groups,
the frequency of severe brain injury, as well as inconsistent
adherence to transfusion protocols and laboratory thresholds
among published trials also cloud the picture.
Recently, the successful resuscitation using whole blood at a
dose of 20 ml/kg was reported in a cohort of 18 pediatric civilian
trauma patients (39). However, more evidence is urgently needed
before the use of whole blood can be recommended in children.
GOAL-DIRECTED HEMOSTATIC
RESUSCITATION
As there is no clear evidence to support ratio driven
transfusion protocols in pediatric trauma patients, goal-directed
transfusion management using viscoelastic testing offers an
alternative approach. Data from an adult pragmatic randomized
trial in 111 trauma patients demonstrated that a group of
patients whose treatment was guided by thrombelastography
had improved survival compared to patients whose treatment
was guided by conventional coagulation tests (40). Higher
blood product utilization, with more units of plasma and
platelets in the first 2 h of resuscitation, occurred in the
group guided by conventional coagulation tests. Survival in
the thrombelastography group was significantly higher than the
conventional coagulation test group. In another adult trauma
trial that compared thromboelastometry-guided transfusion
management with purified concentrates compared to plasma
transfusion vs. a targeted administration, the former group
showed superior outcome (41). Not only was the amount of
transfused allogeneic blood products smaller in the coagulation
factor group, but the time to correct TIC and improve
bleeding was significantly shorter in the coagulation factor-
group (median of 22.5min [IQR; 13.5–40.0] vs. 128.0min [IQR;
48.3–186.3]) vs. the plasma group (estimated time difference
of −97min [−126 to −60], p < 0.0001). Another important
finding of that study was that almost all patients suffered from
severe hypofibrinogenemia after arrival at the emergency room,
which was successfully treated by administration of fibrinogen
concentrate at a dose of 50 mg/kg, while a dose of 30 ml/kg
of plasma failed to normalize plasma fibrinogen levels. The
importance of detecting and treating hypofibrinogenemia early
was also investigated in a prospective cohort study of 517
adult trauma patients (42). Multiple studies have demonstrated
evidence that hypofibrinogenemia is a critical issue in severe
bleeding for pediatric intraoperative and trauma patients (43–
45). One study in pediatric trauma patients analyzed an
institutional transfusion protocol where cryoprecipitate was
not included until the third transfusion package. The authors
found that 11% of all cases had fibrinogen levels below the
detection limit of the assay upon arrival in the emergency
department. They concluded that future renditions of their
Massive Transfusion Protocol (MTP) would have included
cryoprecipitate earlier. Plasma is not adequate to replenish
low fibrinogen levels (32). Viscoelastic testing guided bleeding
management could guide earlier fibrinogen replacement since
acquired hypofibrinogenemia can be detected within 5–10min.
However, the search for a perfect bleedingmanagement approach
is hampered by a marked difference in methodologies between
published trials. Trials have used different coagulation tests
(conventional or viscoelastic testing) and applied different
treatment options (ratio-driven transfusion, administration of
coagulation factors, or a mix of both), thus leading to a variety
of alternative approaches (Figure 1).
An example of a goal-directed pediatric bleeding management
algorithm is displayed in Figure 2. This approach is feasible
even in young children. The combination of viscoelastic testing
plus resuscitation with factor concentrates is appealing as results
are rapidly available to the trauma team and the preparation
of coagulation factors can be performed extremely quickly.
Furthermore, the lower volume and pathogen-inactivated status
of coagulation factors compared to standard blood components
are important for safety in pediatric patients. Rapidly available
testing and blood components are of particular importance as the
management of pediatric trauma patients is further challenged by
difficulties and delays in establishing (large bore) venous access
for phlebotomy and fluid resuscitation.
VENOUS THROMBOEMBOLISM IN
TRAUMA
Children sustaining severe traumatic injuries are not only
threatened by the risk of bleeding, but also have an increased
risk for developing venous thromboembolism (VTE). Although
very young children tend to be protected from VTE by
their quantitative and qualitative developmental differences in
hemostasis (46), the risk factors for VTE in older pediatric
patients are well-established. In addition to individual inherited
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FIGURE 1 | This figure illustrates the various potential treatment options for acutely bleeding trauma patients depicting the considerable differences in coagulation
testing (SLT, standard laboratory testing; VET, viscoelastic testing), treatment options (ratio-driven vs. goal-directed transfusion), blood components (RBC, red blood
cells; FFP, plasma; PLT, platelet concentrates; or CRYO, cryoprecipitate), the use of whole blood (WB), or coagulation factors (Fib, fibrinogen concentrate; PCC,
prothrombin complex concentrate; FXIII, factor XIII concentrate).
or acquired risk factors for thrombosis, multiple disease- or
treatment-related risk factors contribute to VTE (47). The
incidence of VTE in pediatric trauma patients is < 0.5% (48–
50). This is in sharp contrast to the adult trauma patient
population where the estimated incidence is as high as 20–
58% without appropriate thromboprophylaxis (47). However,
there is a paucity of evidence for standardized VTE screening
in children and thus children are monitored for VTEs less
frequently so the actual incidence may differ. Additional risk
factors such as major surgery, placement of a central venous
line, injury severity score, age, poor perfusion with necessity
for inotrope support, Glasgow coma scale, intubation, and
blood transfusion have been identified as contributors to
VTE risk.
Although there is currently no consensus for routine
administration of thromboembolism prophylaxis in the pediatric
trauma setting, a group from Johns Hopkins created their
own VTE prediction score based on risk factors identified
in their risk assessment model (50). A retrospective review
of a pediatric trauma registry encompassing 13,880 patients
found no VTE in the age group < 13 years, two VTEs in
the age group 13–17 years, and 59 VTEs in the age group
> 17 years old (51). A consensus conference regarding
the prevention of VTE in pediatric trauma patients judged
current scientific data as insufficient for evidence-based
decisions. However, they provided the recommendation that
injured children < 12 years old do not routinely need VTE
prophylaxis, but prophylaxis should be considered in children
with a history of VTE, and may be considered in children
with a central venous catheter (52). A recently published
retrospective cohort of 209 pediatric trauma patients showed that
femoral venous catheter-associated thrombosis is significantly
more frequent than in non-femoral catheters (53). When
thromboembolism prophylaxis with low-molecular-weight
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FIGURE 2 | Example of a goal-directed pediatric bleeding management algorithm. TXA, tranexamic acid; RBC, red blood cells; S/D plasma AB, solvent/detergent
pooled plasma, blood group AB.
heparin was administered to a cohort of 706 pediatric trauma
patients, major bleeding was reported in 0.4% of those
children, while thromboembolic events were detected in
2.1% (54).
CONCLUSIONS AND FUTURE
DIRECTIONS
At present, the knowledge regarding hemostatic balance
in severe pediatric trauma patients is mostly extrapolated
from adults. More studies are urgently needed to understand
the pathophysiologic changes in this patient population.
Trauma-induced coagulopathy is not just one single entity,
but a heterogenous group of hemostatic imbalances showing
distinct phenotypes depending on timing, mechanism of injury,
underlying conditions and other less understood factors. The
conditions are even more heterogeneous in children, where
the age of the children impacts the mechanism of injury as
well the baseline hemostatic factors. As such, a rapid, frequent
and reliable laboratory testing should be performed to detect
the current and evolving clinical picture. Coagulation tests
such as INR or PT may not accurately assess the hemostatic
imbalance and may lead to over transfusion of plasma without
improving the outcome. The implementation of a viscoelastic
testing protocol has been beneficial in adult trauma treatment
and should be validated in the pediatric setting. A targeted
transfusion approach may offer a feasible alternative in
pediatric bleeding management, with focus on the treatment
of hyperfibrinolysis and hypofibrinogenemia. Although
thromboembolism prophylaxis is not generally recommended in
pediatric trauma patients < 12 years old, future studies should
investigate whether viscoelastic testing can be used to predict
thrombosis, thus giving a more global picture of hemostatic
balance in this patient population.
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